Amalgamated Bank trimmed its holdings in Clarivate Plc (NYSE:CLVT – Free Report) by 8.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,717 shares of the company’s stock after selling 2,023 shares during the period. Amalgamated Bank’s holdings in Clarivate were worth $124,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in CLVT. Nisa Investment Advisors LLC bought a new stake in Clarivate during the second quarter worth about $26,000. Evermay Wealth Management LLC acquired a new stake in Clarivate in the first quarter worth $31,000. Forum Financial Management LP bought a new stake in shares of Clarivate during the second quarter worth about $75,000. J.W. Cole Advisors Inc. purchased a new stake in shares of Clarivate in the first quarter worth approximately $76,000. Finally, Headlands Technologies LLC lifted its holdings in shares of Clarivate by 749.2% in the second quarter. Headlands Technologies LLC now owns 14,632 shares of the company’s stock valued at $83,000 after purchasing an additional 12,909 shares in the last quarter. 85.72% of the stock is currently owned by institutional investors.
Clarivate Price Performance
Shares of NYSE:CLVT opened at $6.59 on Wednesday. The company’s fifty day moving average price is $6.53 and its 200-day moving average price is $6.43. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.90 and a quick ratio of 0.90. The firm has a market capitalization of $4.40 billion, a price-to-earnings ratio of -3.97 and a beta of 1.17. Clarivate Plc has a one year low of $4.97 and a one year high of $9.60.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the company. Barclays reduced their price objective on Clarivate from $6.00 to $5.00 and set an “underweight” rating for the company in a research note on Wednesday, August 7th. Royal Bank of Canada dropped their target price on Clarivate from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $7.71.
Check Out Our Latest Research Report on Clarivate
Insider Buying and Selling at Clarivate
In other Clarivate news, Director Andrew Miles Snyder purchased 28,938 shares of the business’s stock in a transaction on Thursday, August 8th. The stock was acquired at an average cost of $5.49 per share, for a total transaction of $158,869.62. Following the completion of the transaction, the director now directly owns 288,334 shares in the company, valued at approximately $1,582,953.66. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Andrew Miles Snyder acquired 28,938 shares of the company’s stock in a transaction dated Thursday, August 8th. The stock was purchased at an average price of $5.49 per share, with a total value of $158,869.62. Following the completion of the purchase, the director now owns 288,334 shares in the company, valued at approximately $1,582,953.66. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Bar Veinstein sold 120,000 shares of Clarivate stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $7.00, for a total transaction of $840,000.00. Following the completion of the transaction, the insider now directly owns 976,583 shares in the company, valued at $6,836,081. The disclosure for this sale can be found here. Company insiders own 22.77% of the company’s stock.
Clarivate Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Stories
- Five stocks we like better than Clarivate
- What is a Secondary Public Offering? What Investors Need to Know
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Invest in Biotech Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- The How And Why of Investing in Oil Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVT – Free Report).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.